王勇

发布者:2023-09-04发布者:1051

1. Rongze Wang, Keze Hong, Qiaoyun Zhang, Jianrong Cao, Tao Huang, Zecong Xiao*, Yong Wang*, Xintao Shuai. A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer. Acta Biomaterialia, 2023, https://doi.org/10.1016/j.actbio.2023.08.007. IF: 9.7

2. Tao Huang, Qiaoyun Zhang, Jing Yi, Rongze Wang, Zekun Zhang, Pin Luo, Rong Zeng, Yong Wang*, Mei Tu*. PEG-sheddable nanodrug remodels tumor microenvironment to promote effector T cell infiltration and revise their exhaustion for breast cancer immunotherapy. Small, 2023, 2301749. https://doi.org/10.1002/smll.202301749. IF: 13.3

3. Jinsheng Huang*, Huiling Huang, Yiyao Wang, Bin Xu, Minzhao Lin, Shisong Han, Yuanyuan Yuan*, Yong Wang*, Xintao Shuai*. Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation. Biomaterials, 2023, 299, 122134. IF: 14.0

4. Zecong Xiao, Yitong Tan, Yujun Cai, Jinsheng Huang, Xiaobin Wang, Bo Li, Liteng Lin, Yong Wang*, Xintao Shuai*, Kangshun Zhu*. Nanodrug removes physical barrier to promote T-cell infiltration for enhanced cancer immunotherapy. Journal of Controlled Release, 2023, 356, 360-372. IF: 10.8

5. Xiaobin Wang, Qiaoyun Zhang, Jingwen Zhou, Zecong Xiao, Jianxin Liu, Shaohui Deng, Xiaoyang Hong, Wensou Huang, Mingyue Cai, Yongjian Guo, Jingjun Huang, Yong Wang*, Liteng Lin*, Kangshun Zhu*. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer, 2023, 11, e006493. IF: 10.9

6. Zecong Xiao, Tan Li, Xinyao Zheng, Liteng Lin, Xiaobin Wang, Bo Li, Jingjun Huang, Yong Wang*, Xintao Shuai*, Kangshun Zhu*. Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation. Bioactive Materials, 2023, 21, 57-68. IF: 18.9

7. Zecong Xiao, Yujun Cai, Xiaobin Wang, Lijun Hu, Minzhao Lin, Kangshun Zhu*, Yong Wang*, Xintao Shuai*. Nanodrug simultaneously regulates stromal extracellular matrix and glucose metabolism for effective immunotherapy against orthotopic pancreatic cancer. Nano Today, 2022, 44, 101490. IF: 17.4

8. Jinsheng Huang, Chujie Zheng, Hong Xiao, Huiling Huang, Yiyao Wang, Minzhao Lin, Jun Pang, Yong Wang*, Yuanyuan Yuan*, XintaoShuai*. A polymercalcium phosphate nanocapsule for RNAi-induced oxidative stress and cascaded chemotherapy. Journal of Controlled Release, 2021, 340, 259-270. IF: 10.8

9. Jinsheng Huang, Zecong Xiao, Yongcheng An, Shisong Han, Wei Wu, Yong Wang*, Yu Guo*, Xintao Shuai*. Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy. Biomaterials, 2021, 269, 120636. IF: 14.0

10. Liteng  Lin, Hengye Gong, Rui Li, Jingjun Huang, Mingyue Cai, Tian Lan, Wensou  Huang, Yongjian Guo, Zhimei Zhou, Yongcheng An, Zhiwei Chen, Licong  Liang, Yong Wang*,  Xintao Shuai*, Kangshun Zhu*, Nanodrug with ROS and pH dual-sensitivity  ameliorates liver fibrosis via multicellular regulation. Advanced Science, 2020, 7: 1903138. IF: 15.1

(*为通讯作者)